These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3283094)
21. Aztreonam in the treatment of serious gram-negative infections in the elderly. Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli. Clergeot A; Steru D; Rosset MA; Carbon C Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476 [TBL] [Abstract][Full Text] [Related]
23. Empiric antibiotic use--aztreonam as a model. Levin S Am J Med; 1990 Mar; 88(3C):21S-23S; discussion 38S-42S. PubMed ID: 2316555 [TBL] [Abstract][Full Text] [Related]
24. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli. DeMaria A; Treadwell TL; Saunders CA; Porat R; McCabe WR Antimicrob Agents Chemother; 1989 Aug; 33(8):1137-43. PubMed ID: 2679368 [TBL] [Abstract][Full Text] [Related]
30. The clinical use of aztreonam. Schönwald S; Schoss-Vidensek Z; Car V; Krznar B Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections. LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751 [TBL] [Abstract][Full Text] [Related]
32. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections. Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296 [TBL] [Abstract][Full Text] [Related]
33. Clinical studies of aztreonam in Japan. Hara K; Kobayashi H; Nishiura T; Yura J; Saito A Rev Infect Dis; 1985; 7 Suppl 4():S810-24. PubMed ID: 3909341 [TBL] [Abstract][Full Text] [Related]
34. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis. Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; Vaneechoutte M; Boelaert J; Schurgers M; Van Landuyt H; Verbeelen D Rev Infect Dis; 1991; 13 Suppl 7():S645-7. PubMed ID: 2068475 [TBL] [Abstract][Full Text] [Related]
35. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections. Birolini D; Moraes MF; de Souza OS Rev Infect Dis; 1985; 7 Suppl 4():S724-8. PubMed ID: 3909330 [TBL] [Abstract][Full Text] [Related]
36. A comparison of monobactam antibiotics in surgical infections. DiPiro JT; Bowden TA Am J Surg; 1989 Jun; 157(6):607-14. PubMed ID: 2658643 [TBL] [Abstract][Full Text] [Related]
37. Aztreonam. Cunha BA Urology; 1993 Mar; 41(3):249-58. PubMed ID: 8442309 [TBL] [Abstract][Full Text] [Related]
38. Aztreonam therapy for serious gram-negative infections in children. Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490 [TBL] [Abstract][Full Text] [Related]